$CTV
Innovid Corp. Stock $ctv

$ctv Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000183537822000122 Filed on August 10, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$34.47M	$33.09M	$25.86M
YoY Change	-46.41%	44.86%	43.57%
Cost Of Revenue	$8.534M	$7.351M	$6.344M
YoY Change	-31.28%	85.26%	64.27%
Gross Profit	$25.94M	$25.74M	$19.52M
YoY Change	-50.03%	36.36%	37.93%
Gross Profit Margin	75.24%	77.78%	75.47%
Selling, General & Admin	$22.77M	$24.28M	$21.99M
YoY Change	-33.26%	97.28%	143.15%
% of Gross Profit	87.8%	94.32%	112.64%
Research & Development	$7.312M	$9.710M	$7.329M
YoY Change	-56.82%	58.38%	38.36%
% of Gross Profit	28.19%	37.73%	37.55%
Depreciation & Amortization	$1.882M	$926.0K	$673.0K
YoY Change	1106.41%	521.48%	269.78%
% of Gross Profit	7.26%	3.6%	3.45%
Operating Expenses	$30.08M	$33.99M	$29.32M
YoY Change	-41.07%	84.34%	104.44%
Operating Profit	-$6.031M	-$9.174M	-$9.797M
YoY Change	-807.03%	-3274.39%	5111.17%
Interest Expense	-$4.962M	$13.31M	$2.311M
YoY Change	27.95%	-930.59%	-247.29%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$10.99M	$4.132M	-$7.486M
YoY Change	263.4%	-414.7%	326.07%
Income Tax	$839.0K	-$168.0K	-$37.00K
% Of Pretax Income		-4.07%
Net Earnings	-$11.83M	$4.300M	-$7.449M
YoY Change	207.01%	-359.19%	284.76%
Net Earnings / Revenue	-34.33%	13.0%	-28.8%
Basic Earnings Per Share	-$0.09	$0.03	-$0.06
Diluted Earnings Per Share	-$0.09	$0.03	-$0.06
COMMON SHARES
Basic Shares Outstanding	132.4M shares	132.2M shares	124.2M shares
Diluted Shares Outstanding	133.0M shares	140.0M shares	124.2M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.51M	$44.02M	$45.44M
YoY Change	221.37%	15095.89%	6993.17%
Cash & Equivalents	$46.51M	$44.02M	$45.44M
Short-Term Investments
Other Short-Term Assets	$3.812M	$5.247M	$6.571M
YoY Change	93.9%	735.27%	748.58%
Inventory
Prepaid Expenses
Receivables	$40.22M	$43.55M	$38.77M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$90.54M	$92.82M	$90.78M
YoY Change	78.73%	6970.2%	4915.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.72M	$8.862M	$6.599M
YoY Change	255.34%
Goodwill	$114.7M	$114.6M	$97.20M
YoY Change
Intangibles	$34.21M	$35.14M	$59.27M
YoY Change
Long-Term Investments	$310.0K	$312.0K	$303.0K
YoY Change	-2.21%	-99.88%	-99.88%
Other Assets	$795.0K	$625.0K	$542.0K
YoY Change	-81.6%
Total Long-Term Assets	$165.3M	$163.0M	$167.9M
YoY Change	1223.6%	-35.57%	-33.66%
TOTAL ASSETS
Total Short-Term Assets	$90.54M	$92.82M	$90.78M
Total Long-Term Assets	$165.3M	$163.0M	$167.9M
Total Assets	$255.9M	$255.8M	$258.6M
YoY Change	305.17%	0.59%	1.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.950M	$3.661M	$3.791M
YoY Change	15.05%	3190.49%
Accrued Expenses	$6.573M	$4.662M	$4.183M
YoY Change	-42.53%	1337.11%	730.36%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$15.00M	$6.000M
YoY Change
Total Short-Term Liabilities	$22.11M	$34.51M	$25.81M
YoY Change	57.9%	7820.63%	5024.27%
LONG-TERM LIABILITIES
Long-Term Debt	$15.00M	$0.00	$0.00
YoY Change	150.0%
Other Long-Term Liabilities	$3.918M	$3.831M	$10.47M
YoY Change	-40.13%	-90.57%	-74.03%
Total Long-Term Liabilities	$28.79M	$9.321M	$29.91M
YoY Change	129.49%	-77.07%	-25.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.11M	$34.51M	$25.81M
Total Long-Term Liabilities	$28.79M	$9.321M	$29.91M
Total Liabilities	$50.90M	$43.83M	$55.72M
YoY Change	91.73%	6.69%	36.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$147.5M	-$135.6M	-$139.9M
YoY Change
Common Stock	$13.00K	$13.00K	$13.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$205.0M	$212.0M	$202.9M
YoY Change
Total Liabilities & Shareholders Equity	$255.9M	$255.8M	$258.6M
YoY Change	305.17%	0.59%	1.5%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$11.83M	$4.300M	-$7.449M
YoY Change	207.01%	-359.19%	284.76%
Depreciation, Depletion And Amortization	$1.882M	$926.0K	$673.0K
YoY Change	1106.41%	521.48%	269.78%
Cash From Operating Activities	$5.813M	-$8.688M	-$7.213M
YoY Change	-546.81%	999.75%	-240.41%
INVESTING ACTIVITIES
Capital Expenditures	-$3.520M	-$1.969M	$97.00K
YoY Change	207.96%	1540.83%	-40.85%
Acquisitions			$99.57M
YoY Change
Other Investing Activities	$6.000K	$29.00K	-$99.57M
YoY Change	-117.65%	-105.87%	-905236.36%
Cash From Investing Activities	-$3.514M	-$1.940M	-$101.3M
YoY Change	198.56%	215.96%	66130.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$0.00
YoY Change
Cash From Financing Activities	181.0K	9.169M	-$2.718M
YoY Change	-64.85%	-408.51%	-1610.0%
NET CHANGE
Cash From Operating Activities	5.813M	-8.688M	-$7.213M
Cash From Investing Activities	-3.514M	-1.940M	-$101.3M
Cash From Financing Activities	181.0K	9.169M	-$2.718M
Net Change In Cash	2.480M	-1.459M	-$111.3M
YoY Change	-226.34%	-66.66%	-2254.61%
FREE CASH FLOW
Cash From Operating Activities	$5.813M	-$8.688M	-$7.213M
Capital Expenditures	-$3.520M	-$1.969M	$97.00K
Free Cash Flow	$9.333M	-$6.719M	-$7.310M
YoY Change	-6006.96%	902.84%	-246.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001835378
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40048
	dei	Entity Registrant Name EntityRegistrantName	Innovid Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3769599
	dei	Entity Address Address Line1 EntityAddressAddressLine1	30 Irving Place,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10003
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	966-7555
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	132443951	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44024000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156696000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	69000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	81000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43553000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35422000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5247000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3131000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	92824000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	195249000	usd
CY2022Q2	iacb	Long Term Other Deposit LongTermOtherDeposit	312000	usd
CY2021Q4	iacb	Long Term Other Deposit LongTermOtherDeposit	310000	usd
CY2022Q2	iacb	Long Term Restricted Deposit LongTermRestrictedDeposit	411000	usd
CY2021Q4	iacb	Long Term Restricted Deposit LongTermRestrictedDeposit	462000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8862000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4840000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	114608000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	4555000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	35135000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3069000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	625000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	116000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	163022000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	10283000	usd
CY2022Q2	us-gaap	Assets Assets	255846000	usd
CY2021Q4	us-gaap	Assets Assets	205532000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3661000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5026000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9499000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7742000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4662000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3082000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	15000000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1685000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	34507000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21850000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2464000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3831000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3455000	usd
CY2022Q2	iacb	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	3026000	usd
CY2021Q4	iacb	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	18972000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9321000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22427000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	43828000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	44277000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	132411715	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132411715	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119017380	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119017380	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	347630000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	293719000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135625000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132476000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	212018000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161255000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	255846000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	205532000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33088000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22842000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	58950000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40855000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	7351000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	3968000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	13277000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7811000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9710000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6131000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16964000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11356000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14320000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8105000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24671000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14677000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9955000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4200000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21410000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6579000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	926000	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1599000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	331000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9174000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	289000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18971000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	101000	usd
CY2022Q2	iacb	Finance Expenses Net FinanceExpensesNet	-13306000	usd
CY2021Q2	iacb	Finance Expenses Net FinanceExpensesNet	1602000	usd
	iacb	Finance Expenses Net FinanceExpensesNet	-15617000	usd
	iacb	Finance Expenses Net FinanceExpensesNet	3171000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4132000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1313000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3354000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3070000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-168000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	346000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-205000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	525000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	4300000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1659000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3149000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3595000	usd
CY2022Q2	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	usd
CY2021Q2	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	21076000	usd
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	usd
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	44804000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4300000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4300000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22735000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22735000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3149000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3149000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-48399000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-48399000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.85
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.85
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132152652	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17116586	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128220893	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16956139	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139988123	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17116586	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	128220893	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16956139	shares
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	86997000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-49730000	usd
CY2021Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	23728000	usd
CY2021Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	23728000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	280000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	306000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1936000	usd
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110725000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-74808000	usd
CY2021Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	21076000	usd
CY2021Q2	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	21076000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1440000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	61000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1659000	usd
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	131801000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-96042000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161255000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	47152000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1496000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	462000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7449000	usd
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	202916000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4628000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	174000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	4300000	usd
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	212018000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3149000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3595000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1599000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	331000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5634000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1720000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-15946000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2728000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4624000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2605000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	747000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	623000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-321000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	238000	usd
	iacb	Decrease In Operating Lease Right Of Use Assets DecreaseInOperatingLeaseRightOfUseAssets	872000	usd
	iacb	Decrease In Operating Lease Right Of Use Assets DecreaseInOperatingLeaseRightOfUseAssets	0	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1044000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	184000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1208000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	945000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	759000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15901000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4347000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	99568000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3516000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	221000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	284000	usd
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	0	usd
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	459000	usd
	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	32000	usd
	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	-24000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-103273000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-767000	usd
	iacb	Repayment Of Acquisition Liability RepaymentOfAcquisitionLiability	0	usd
	iacb	Repayment Of Acquisition Liability RepaymentOfAcquisitionLiability	126000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3033000	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	3185000	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	636000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	367000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6451000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2792000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-112723000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	788000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157158000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16092000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44435000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16880000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	363000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	80000	usd
	us-gaap	Interest Paid Net InterestPaidNet	137000	usd
	us-gaap	Interest Paid Net InterestPaidNet	128000	usd
	iacb	Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued	47152000	usd
	iacb	Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued	0	usd
	iacb	Noncash Preferred Stock Accretion Of Redemption Value NoncashPreferredStockAccretionOfRedemptionValue	0	usd
	iacb	Noncash Preferred Stock Accretion Of Redemption Value NoncashPreferredStockAccretionOfRedemptionValue	44804000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1640000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44024000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16441000	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	411000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	439000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44435000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16880000	usd
CY2021Q4	iacb	Temporary Equity Secondary Sale Amount TemporaryEquitySecondarySaleAmount	68855000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Prior period reclassification:<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, we presented depreciation and amortization expenses as a separate line item on our condensed consolidated statements of operations and all prior periods have been adjusted. Depreciation and amortization expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our condensed consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification is to better reflect the financial performance of transactions with customers as our business has evolved and include our most recent acquisition. The change provides more clarity about changes in cost of revenue and other operating expenses exclusive of depreciation and amortization, and better align with how our peers and competitors present their financial statements. </span></div>In accordance with US GAAP, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to common stockholders or net loss per stock for any periods presented. The condensed consolidated balance sheets, condensed statements of changes in temporary equity and stockholders’ equity (deficit), and the condensed consolidated statements of cash flows are not affected by this reclassification.
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	7351000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	3968000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9710000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	iacb	Revenue Recognition Advertisement Serving And Creative Services Percentage RevenueRecognitionAdvertisementServingAndCreativeServicesPercentage	0.832
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6131000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14320000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8105000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9955000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4200000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	926000	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	13277000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7811000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16964000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11356000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24671000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14677000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21410000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6579000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1599000	usd
	iacb	Revenue Recognition Advertisement Serving And Creative Services Percentage RevenueRecognitionAdvertisementServingAndCreativeServicesPercentage	0.985
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	331000	usd
	us-gaap	Use Of Estimates UseOfEstimates	Use of estimates:The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic created, and continues to create significant uncertainty in macroeconomic conditions, including supply chain disruptions and labor shortages. Further, other global events such as the war in the Ukraine and the current macro-economic inflationary environment could have an impact on our customers. Based on public reporting and our observations, some advertisers in certain industries decreased and may continue to decrease their short-term advertising spending in light of some or all of these factors. This in turn could negatively impact our revenues from such advertisers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has considered the impact of COVID-19 and other global events on its estimates and assumptions and determined that there were no material adverse impacts on the unaudited interim condensed consolidated financial statements for the three and six-month period ended June 30, 2022. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company obtained an unsecured loan of $3,516 in April 2020 due to uncertainties related to COVID-19. The loan was obtained through SVB under the PPP Loan pursuant to the CARES Act and Flexibility Act. The Company fully repaid the PPP Loan in June 2021. See Note 6 for further details.</span></div>
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2021Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q2	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.216
CY2021Q2	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.008
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentrations of credit risks:<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s cash and cash equivalents are invested in deposits with major banks in America and Israel. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s trade receivables, net are mainly derived from sales to customers located in the APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.</span></div>The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
	iacb	Revenue From Contract With Customer Payment Term RevenueFromContractWithCustomerPaymentTerm	P60D
CY2022Q2	iacb	Revenue Recognition Advertisement Serving And Creative Services Percentage RevenueRecognitionAdvertisementServingAndCreativeServicesPercentage	0.784
CY2021Q2	iacb	Revenue Recognition Advertisement Serving And Creative Services Percentage RevenueRecognitionAdvertisementServingAndCreativeServicesPercentage	0.985
	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.166
	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.009
CY2021	iacb	Accrued Transaction Cost Not Yet Paid AccruedTransactionCostNotYetPaid	3185000	usd
CY2021	iacb	Temporary Equity Secondary Sale Amount TemporaryEquitySecondarySaleAmount	68855000	usd
CY2021	iacb	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	31160000	usd
CY2021	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	6199000	usd
CY2021	iacb	Net Proceeds From The Transaction Before Secondary Sale Amount NetProceedsFromTheTransactionBeforeSecondarySaleAmount	149252000	usd
CY2021	iacb	Accrued Direct Transaction Cost AccruedDirectTransactionCost	3185000	usd
CY2021	iacb	Warrant Assumed As Part Of Transaction WarrantAssumedAsPartOfTransaction	22791000	usd
CY2021	iacb	Payments Of Reverse Recapitalization Transaction Costs Warrants PaymentsOfReverseRecapitalizationTransactionCostsWarrants	2750000	usd
CY2021	iacb	Reverse Recapitalization Net Of Transaction Costs Before Secondary Sale Amount ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount	126026000	usd
CY2022Q2	iacb	Business Acquisition Accrued Transaction Costs BusinessAcquisitionAccruedTransactionCosts	3185000	usd
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1	shares
CY2021Q4	iacb	Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination	P30D
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3069000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4149000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1685000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2464000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4149000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	472000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	947000	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	126000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	208000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	6000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	10000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	604000	usd
	us-gaap	Lease Cost LeaseCost	1165000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.032
	us-gaap	Operating Lease Payments OperatingLeasePayments	1133000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	995000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1873000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	766000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	703000	usd
CY2022Q2	iacb	Lessee Operating Lease Liability Undiscounted Lease Payments LesseeOperatingLeaseLiabilityUndiscountedLeasePayments	4337000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	188000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4149000	usd
	iacb	Fractional Shares Issued Upon Exercise FractionalSharesIssuedUponExercise	0	shares
	iacb	Threshold Period For Not To Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination	P30D
CY2022Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	13159000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	15946000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	152000	usd
CY2022Q2	us-gaap	Line Of Credit LineOfCredit	15000000	usd
CY2022Q2	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	15000000	usd
CY2022Q2	iacb	Bank Guarantees In Connection With Office Lease Agreement BankGuaranteesInConnectionWithOfficeLeaseAgreement	231000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	490000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	490000	usd
CY2021Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6023000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M4D
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	1916000	usd
	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	118000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	operatingsegment
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33088000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22842000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	58950000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40855000	usd
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	11931000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4840000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	4300000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1659000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3149000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3595000	usd
CY2022Q2	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	0	usd
CY2021Q2	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	21076000	usd
	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	0	usd
	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	44804000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4300000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4300000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22735000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-22735000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3149000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3149000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-48399000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-48399000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132152652	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17116586	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128220893	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16956139	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139988123	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17116586	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	128220893	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16956139	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.85
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.85

Files In Submission

Name	View Source	Status
0001835378-22-000122-index-headers.html	Edgar Link	pending
0001835378-22-000122-index.html	Edgar Link	pending
0001835378-22-000122.txt	Edgar Link	pending
0001835378-22-000122-xbrl.zip	Edgar Link	pending
exhibit101loanandsecurit.htm	Edgar Link	pending
exhibit101loanandsecurit001.jpg	Edgar Link	pending
exhibit101loanandsecurit002.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
exhibit101loanandsecurit003.jpg	Edgar Link	pending
exhibit101loanandsecurit004.jpg	Edgar Link	pending
exhibit101loanandsecurit005.jpg	Edgar Link	pending
exhibit101loanandsecurit006.jpg	Edgar Link	pending
exhibit101loanandsecurit007.jpg	Edgar Link	pending
exhibit101loanandsecurit008.jpg	Edgar Link	pending
exhibit101loanandsecurit009.jpg	Edgar Link	pending
exhibit101loanandsecurit010.jpg	Edgar Link	pending
exhibit101loanandsecurit011.jpg	Edgar Link	pending
exhibit101loanandsecurit012.jpg	Edgar Link	pending
exhibit101loanandsecurit013.jpg	Edgar Link	pending
exhibit101loanandsecurit014.jpg	Edgar Link	pending
exhibit101loanandsecurit015.jpg	Edgar Link	pending
exhibit101loanandsecurit016.jpg	Edgar Link	pending
exhibit101loanandsecurit017.jpg	Edgar Link	pending
exhibit101loanandsecurit018.jpg	Edgar Link	pending
exhibit101loanandsecurit019.jpg	Edgar Link	pending
exhibit101loanandsecurit020.jpg	Edgar Link	pending
exhibit101loanandsecurit021.jpg	Edgar Link	pending
exhibit101loanandsecurit022.jpg	Edgar Link	pending
exhibit101loanandsecurit023.jpg	Edgar Link	pending
exhibit101loanandsecurit024.jpg	Edgar Link	pending
exhibit101loanandsecurit025.jpg	Edgar Link	pending
exhibit101loanandsecurit026.jpg	Edgar Link	pending
exhibit101loanandsecurit027.jpg	Edgar Link	pending
exhibit101loanandsecurit028.jpg	Edgar Link	pending
exhibit101loanandsecurit029.jpg	Edgar Link	pending
exhibit101loanandsecurit030.jpg	Edgar Link	pending
exhibit101loanandsecurit031.jpg	Edgar Link	pending
exhibit101loanandsecurit032.jpg	Edgar Link	pending
exhibit101loanandsecurit033.jpg	Edgar Link	pending
exhibit101loanandsecurit034.jpg	Edgar Link	pending
exhibit101loanandsecurit035.jpg	Edgar Link	pending
exhibit101loanandsecurit036.jpg	Edgar Link	pending
exhibit101loanandsecurit037.jpg	Edgar Link	pending
exhibit101loanandsecurit038.jpg	Edgar Link	pending
exhibit101loanandsecurit039.jpg	Edgar Link	pending
exhibit101loanandsecurit040.jpg	Edgar Link	pending
exhibit101loanandsecurit041.jpg	Edgar Link	pending
exhibit101loanandsecurit042.jpg	Edgar Link	pending
exhibit101loanandsecurit043.jpg	Edgar Link	pending
exhibit101loanandsecurit044.jpg	Edgar Link	pending
exhibit101loanandsecurit045.jpg	Edgar Link	pending
exhibit311q2.htm	Edgar Link	pending
exhibit312q2.htm	Edgar Link	pending
exhibit321q2.htm	Edgar Link	pending
exhibit322q2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iacb-20220630.htm	Edgar Link	pending
iacb-20220630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
iacb-20220630_cal.xml	Edgar Link	unprocessable
iacb-20220630_def.xml	Edgar Link	unprocessable
iacb-20220630_lab.xml	Edgar Link	unprocessable
iacb-20220630_pre.xml	Edgar Link	unprocessable
iacb-20220630_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTV
Innovid Corp. Stock $ctv

2022 Q3 Form 10-Q Financial Statement

#000183537822000122 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTV Innovid Corp. Stock $ctv

2022 Q3 Form 10-Q Financial Statement

#000183537822000122 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTV
Innovid Corp. Stock $ctv